Activation of extracellular signal-regulated kinase 1/2 inhibits type I collagen expression by human skin fibroblasts
Han, J. H.
Kahari, V. M.
- 生命科学－已发表论文 
Treatment with the lipid second messenger, ceramide, activates extracellular signal-regulated kinase-1/2 (ERK1/2), c-Jun N-terminal kinase, and p38 in human skin fibroblasts and induces their collagenase-1 expression (Reunanen, N., Westermarck, J., Hakkinen, L., Holmstrom, T. H, Elo, T., Eriksson, J. E., and Kahari, V.-M. (1998) J. Biol. Chem. 213, 5137-5145). Here we show that C-2-ceramide inhibits expression of type I and III collagen mRNAs in dermal fibroblasts, suppresses pro alpha2(I) collagen promoter activity, and reduces stability of type I collagen mRNAs. The down-regulatory effect of C-2-ceramide on type I collagen mRNA levels was abrogated by protein kinase C inhibitors H7, staurosporine, and Re-31-8220 and potently inhibited by a combination of MEK1,2 inhibitor PD98059 and p38 inhibitor 8B203580. Activation of ERK1/2 by adenovirus-mediated expression of constitutively active MEK1 resulted in marked down-regulation of type I collagen mRNA levels and production in fibroblasts, whereas activation of p38 by constitutively active MAPK kinase-3b and MAPK kinase-6b slightly up-regulated type I collagen expression. These results identify the ERK1/2 signaling cascade as a potent negative regulatory pathway with respect to type I collagen expression in fibroblasts, suggesting that it mediates inhibition of collagen production in response to mitogenic stimulation and transformation.